MD Pediatrix Medical Group, Inc.

NYSE mednax.com


$ 22.23 $ 0.00 (0 %)    

Thursday, 13-Nov-2025 05:20:29 EST
QQQ $ 620.18 $ 0.00 (0 %)
DIA $ 482.43 $ 0.00 (0 %)
SPY $ 682.39 $ 0.00 (0 %)
TLT $ 90.00 $ 0.00 (0 %)
GLD $ 390.21 $ 0.00 (0 %)
$ 22.69
$ 22.51
$ 21.38 x 40
$ 23.22 x 22
-- - --
$ 11.84 - $ 22.98
817,134
na
1.95B
$ 0.70
$ 11.95
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-03-2025 09-30-2025 10-Q
2 08-05-2025 06-30-2025 10-Q
3 05-06-2025 03-31-2025 10-Q
4 02-20-2025 12-31-2024 10-K
5 11-01-2024 09-30-2024 10-Q
6 08-06-2024 06-30-2024 10-Q
7 05-07-2024 03-31-2024 10-Q
8 02-20-2024 12-31-2023 10-K
9 11-02-2023 09-30-2023 10-Q
10 08-03-2023 06-30-2023 10-Q
11 05-02-2023 03-31-2023 10-Q
12 02-17-2023 12-31-2022 10-K
13 11-03-2022 09-30-2022 10-Q
14 08-04-2022 06-30-2022 10-Q
15 04-28-2022 03-31-2022 10-Q
16 02-17-2022 12-31-2021 10-K
17 10-28-2021 09-30-2021 10-Q
18 08-06-2021 06-30-2021 10-Q
19 05-07-2021 03-31-2021 10-Q
20 02-18-2021 12-31-2020 10-K
21 11-06-2020 09-30-2020 10-Q
22 07-30-2020 06-30-2020 10-Q
23 05-07-2020 03-31-2020 10-Q
24 02-20-2020 12-31-2019 10-K
25 11-01-2019 09-30-2019 10-Q
26 08-01-2019 06-30-2019 10-Q
27 05-02-2019 03-31-2019 10-Q
28 02-14-2019 12-31-2018 10-K
29 11-01-2018 09-30-2018 10-Q
30 08-02-2018 06-30-2018 10-Q
31 05-04-2018 03-31-2018 10-Q
32 02-14-2018 12-31-2017 10-K
33 11-01-2017 09-30-2017 10-Q
34 07-28-2017 06-30-2017 10-Q
35 05-04-2017 03-31-2017 10-Q
36 02-10-2017 12-31-2016 10-K
37 10-27-2016 09-30-2016 10-Q
38 07-28-2016 06-30-2016 10-Q
39 04-28-2016 03-31-2016 10-Q
40 02-11-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 truist-securities-maintains-hold-on-pediatrix-medical-group-raises-price-target-to-24

Truist Securities analyst David Macdonald maintains Pediatrix Medical Group (NYSE:MD) with a Hold and raises the price targe...

 ubs-maintains-neutral-on-pediatrix-medical-group-raises-price-target-to-23

UBS analyst A.J. Rice maintains Pediatrix Medical Group (NYSE:MD) with a Neutral and raises the price target from $16.5 to $23.

 pediatrix-medical-group-q3-adj-eps-067-beats-047-estimate-sales-492875m-beat-476493m-estimate

Pediatrix Medical Group (NYSE:MD) reported quarterly earnings of $0.67 per share which beat the analyst consensus estimate of $...

 leerink-partners-maintains-market-perform-on-pediatrix-medical-group-raises-price-target-to-17

Leerink Partners analyst Whit Mayo maintains Pediatrix Medical Group (NYSE:MD) with a Market Perform and raises the price ta...

 pediatrix-medical-group-authorizes-250m-share-repurchase-program

Pediatrix Medical Group, Inc. (NYSE:MD), a leading provider of physician services, today announced that its Board of Directors ...

 ubs-maintains-neutral-on-pediatrix-medical-group-raises-price-target-to-165

UBS analyst A.J. Rice maintains Pediatrix Medical Group (NYSE:MD) with a Neutral and raises the price target from $16 to $16.5.

 pediatrix-medical-group-q2-adj-eps-053-beats-042-estimate-sales-468844m-beat-464324m-estimate

Pediatrix Medical Group (NYSE:MD) reported quarterly earnings of $0.53 per share which beat the analyst consensus estimate of $...

 ubs-maintains-neutral-on-pediatrix-medical-group-lowers-price-target-to-16

UBS analyst A.J. Rice maintains Pediatrix Medical Group (NYSE:MD) with a Neutral and lowers the price target from $18.5 to $16.

 macquarie-maintains-outperform-on-pediatrix-medical-group-raises-price-target-to-20

Macquarie analyst Tao Qiu maintains Pediatrix Medical Group (NYSE:MD) with a Outperform and raises the price target from $19...

 pediatrix-medical-group-q1-adj-eps-033-beats-024-estimate-sales-45836m-beat-45150m-estimate

Pediatrix Medical Group (NYSE:MD) reported quarterly earnings of $0.33 per share which beat the analyst consensus estimate of $...

 truist-securities-maintains-hold-on-pediatrix-medical-group-lowers-price-target-to-16

Truist Securities analyst David Macdonald maintains Pediatrix Medical Group (NYSE:MD) with a Hold and lowers the price targe...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION